Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.

Lyttle Schumacher B, Grover N, Mesen T, Steiner A, Mersereau J.

Hum Reprod. 2017 Oct 1;32(10):2049-2055. doi: 10.1093/humrep/dex257.

2.

Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.

Goldman RH, Racowsky C, Farland LV, Munné S, Ribustello L, Fox JH.

Hum Reprod. 2017 Apr 1;32(4):853-859. doi: 10.1093/humrep/dex008.

PMID:
28166330
3.

Optimal timing for elective egg freezing.

Mesen TB, Mersereau JE, Kane JB, Steiner AZ.

Fertil Steril. 2015 Jun;103(6):1551-6.e1-4. doi: 10.1016/j.fertnstert.2015.03.002. Epub 2015 Apr 14.

4.

Assisted reproductive technology use and outcomes among women with a history of cancer.

Luke B, Brown MB, Missmer SA, Spector LG, Leach RE, Williams M, Koch L, Smith YR, Stern JE, Ball GD, Schymura MJ.

Hum Reprod. 2016 Jan;31(1):183-9. doi: 10.1093/humrep/dev288. Epub 2015 Nov 17.

5.

Fertility preservation for social indications: a cost-based decision analysis.

Hirshfeld-Cytron J, Grobman WA, Milad MP.

Fertil Steril. 2012 Mar;97(3):665-70. doi: 10.1016/j.fertnstert.2011.12.029. Epub 2012 Jan 21.

PMID:
22265038
6.

Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.

Abir R, Ben-Aharon I, Garor R, Yaniv I, Ash S, Stemmer SM, Ben-Haroush A, Freud E, Kravarusic D, Sapir O, Fisch B.

Hum Reprod. 2016 Apr;31(4):750-62. doi: 10.1093/humrep/dew007. Epub 2016 Feb 4.

PMID:
26848188
7.

Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.

Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N.

Hum Reprod. 2016 Mar;31(3):623-9. doi: 10.1093/humrep/dev325. Epub 2016 Jan 11.

PMID:
26759139
9.

Baby budgeting: oocyte cryopreservation in women delaying reproduction can reduce cost per live birth.

Devine K, Mumford SL, Goldman KN, Hodes-Wertz B, Druckenmiller S, Propst AM, Noyes N.

Fertil Steril. 2015 Jun;103(6):1446-53.e1-2. doi: 10.1016/j.fertnstert.2015.02.029. Epub 2015 Mar 23.

10.

Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.

Martinez F; International Society for Fertility Preservation–ESHRE–ASRM Expert Working Group.

Fertil Steril. 2017 Sep;108(3):407-415.e11. doi: 10.1016/j.fertnstert.2017.05.024. Epub 2017 Jul 21.

11.

Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.

Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ.

Fertil Steril. 2016 Feb;105(2):459-66.e2. doi: 10.1016/j.fertnstert.2015.10.026. Epub 2015 Nov 18.

PMID:
26604065
12.

Transgender men's experiences of fertility preservation: a qualitative study.

Armuand G, Dhejne C, Olofsson JI, Rodriguez-Wallberg KA.

Hum Reprod. 2017 Feb;32(2):383-390. doi: 10.1093/humrep/dew323. Epub 2016 Dec 19.

PMID:
27999119
13.

Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.

Groen H, Tonch N, Simons AH, van der Veen F, Hoek A, Land JA.

Hum Reprod. 2013 Dec;28(12):3236-46. doi: 10.1093/humrep/det386. Epub 2013 Oct 27.

PMID:
24166594
14.

A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.

Le KD, Vuong LN, Ho TM, Dang VQ, Pham TD, Pham CT, Norman RJ, Mol BWJ.

Hum Reprod. 2018 Oct 1;33(10):1907-1914. doi: 10.1093/humrep/dey253.

PMID:
30239784
15.

Cost-effectiveness analysis of lifestyle intervention in obese infertile women.

van Oers AM, Mutsaerts MAQ, Burggraaff JM, Kuchenbecker WKH, Perquin DAM, Koks CAM, van Golde R, Kaaijk EM, Schierbeek JM, Klijn NF, van Kasteren YM, Land JA, Mol BWJ, Hoek A, Groen H; LIFEstyle study group.

Hum Reprod. 2017 Jul 1;32(7):1418-1426. doi: 10.1093/humrep/dex092.

PMID:
28486704
16.

Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.

Alvarez RM, Ramanathan P.

Hum Reprod. 2016 Jul 1. pii: dew158. [Epub ahead of print]

PMID:
27370358
17.

Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.

Letourneau JM, Sinha N, Wald K, Harris E, Quinn M, Imbar T, Mok-Lin E, Chien AJ, Rosen M.

Hum Reprod. 2017 Oct 1;32(10):2123-2129. doi: 10.1093/humrep/dex276.

PMID:
28938748
18.

Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive.

Baysal Ö, Bastings L, Beerendonk CC, Postma SA, IntHout J, Verhaak CM, Braat DD, Nelen WL.

Hum Reprod. 2015 Jul;30(7):1625-34. doi: 10.1093/humrep/dev116. Epub 2015 Jun 1.

PMID:
26034191
19.

Reproductive choices and outcomes after freezing oocytes for medical reasons: a follow-up study.

Dahhan T, Dancet EA, Miedema DV, van der Veen F, Goddijn M.

Hum Reprod. 2014 Sep;29(9):1925-30. doi: 10.1093/humrep/deu137. Epub 2014 Jun 20.

PMID:
24951490
20.

What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?

Sonigo C, Simon C, Boubaya M, Benoit A, Sifer C, Sermondade N, Grynberg M.

Hum Reprod. 2016 Jul;31(7):1493-500. doi: 10.1093/humrep/dew102. Epub 2016 May 10.

PMID:
27165625

Supplemental Content

Support Center